Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for CHC Healthcare Group (4164:TWSE), powered by AI.
CHC Healthcare Group is currently trading at $30.95. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for CHC Healthcare Group on Alpha Lenz.
CHC Healthcare Group's P/E ratio is 30.7.
“CHC Healthcare Group trades at a P/E of 30.7 (premium valuation) with modest ROE of 2.6%. 3Y revenue CAGR of 13.9% highlights clear growth momentum.”
Ask for details →CHC Healthcare Group operates as a healthcare sector entity specializing in the distribution and maintenance of advanced medical imaging equipment. Their primary function is to enhance medical facilities' capabilities by providing state-of-the-art imaging solutions, thereby improving diagnostic accuracy and patient care. CHC Healthcare Group is known for its comprehensive services that cover everything from equipment installation to comprehensive maintenance and after-sales support. This ensures that healthcare providers can rely on uninterrupted service delivery and focus on patient outcomes. The company plays a critical role in the healthcare sector, impacting hospitals, diagnostic centers, and clinics across various regions. By partnering with leading global manufacturers in medical imaging technology, CHC Healthcare Group brings the latest advancements in imaging tools to the forefront, thereby driving the adoption of cutting-edge medical practices in the healthcare industry. Its market presence is significant, as it bridges the gap between innovative medical technology and clinical application, contributing to the overall improvement of healthcare quality and operational efficiency.
“CHC Healthcare Group trades at a P/E of 30.7 (premium valuation) with modest ROE of 2.6%. 3Y revenue CAGR of 13.9% highlights clear growth momentum.”
Ask for details →